{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:38:14Z","timestamp":1790113094880,"version":"4.0.1"},"reference-count":58,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Several molecular subclassifications of diffuse large B-cell lymphoma (DLBCL) with prognostic and therapeutic potential have been proposed; however, validation in diverse populations and real-world clinical settings remains limited. We investigated the genetic subtypes of Korean DLBCL using the LymphGen classifier and an institutionally developed 121-gene targeted next-generation sequencing (NGS) panel. We also assessed quality control metrics, copy number reliability, and benchmarking performance against an external reference data set (Memorial Sloan Kettering Cancer Center\u2013Integrated Mutation Profiling Actionable Cancer Targets). LymphGen subtypes differed by entity. Patients with DLBCL, not otherwise specified (DLBCL-NOS; n = 123) were classified as MCD (25.2%), A53 (14.6%), ST2 (7.3%), BN2 (5.7%), EZB (3.3%), composite EZB\/ST2 (1.6%), and unclassified (\u201cother\u201d; 42.3%). Patients with primary DLBCLs of the central nervous system (n = 77) were classified as MCD (70.1%), composite MCD\/A53 (2.6%), A53 (3.9%), BN2 (2.6%), ST2 (1.3%), EZB (1.3%), and \u201cother\u201d (18.2%). Compared with Western cohorts, the LymphGen subtype distribution in our Korean DLBCL-NOS cohort differed notably, with MCD being significantly more prevalent. The MCD subtype tended to be associated with non\u2013germinal center B-cell\u2013like DLBCL and DLBCL with MYC\/BCL2 double expression (DE). In R-CHOP (rituximab, cyclophosphamide, doxorubicin, Oncovin [vincristine], and prednisone)-treated DLBCL-NOS, patients with MCD, BN2, and A53 subtypes had poorer overall survival than those with EZB and ST2, particularly among patients with concurrent MYC\/BCL2 DE. Using a clinically applicable NGS panel, we successfully implemented the LymphGen classification system. This study underscores the distinct genetic landscape of Korean DLBCL and highlights the utility of LymphGen in identifying high-risk subgroups, providing a basis for prognostic stratification and therapeutic optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017049","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:06:09Z","timestamp":1768593969000},"page":"1929-1942","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Distribution and prognostic impact of LymphGen subtypes in Korean diffuse large B-cell lymphoma using clinical NGS panel"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-7486","authenticated-orcid":false,"given":"Jeemin","family":"Yim","sequence":"first","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"2Department of Pathology, Seoul Metropolitan Government\u2013Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3458-1440","authenticated-orcid":false,"given":"Sungyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"3Department of Genomic Medicine, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"4Healthcare AI Research Institute, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6640-3051","authenticated-orcid":false,"given":"Sehui","family":"Kim","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Korea University Guro Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-7415","authenticated-orcid":false,"given":"Bogyeong","family":"Han","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"6Department of Pathology, Samsung Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7420-977X","authenticated-orcid":false,"given":"Sojung","family":"Lim","sequence":"additional","affiliation":[{"name":"7Department of Forensic Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0192-7238","authenticated-orcid":false,"given":"Young Keun","family":"Song","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6210-7796","authenticated-orcid":false,"given":"Jeonghwan","family":"Youk","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"10Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-3072","authenticated-orcid":false,"given":"Jeong Mo","family":"Bae","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7687-6477","authenticated-orcid":false,"given":"Jiwon","family":"Koh","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"10Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-8529","authenticated-orcid":false,"given":"Cheol","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8253-2881","authenticated-orcid":false,"given":"Young A","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"2Department of Pathology, Seoul Metropolitan Government\u2013Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-0419","authenticated-orcid":false,"given":"Jin Ho","family":"Paik","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"11Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-4426","authenticated-orcid":false,"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"10Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-5954","authenticated-orcid":false,"given":"Hongseok","family":"Yun","sequence":"additional","affiliation":[{"name":"3Department of Genomic Medicine, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-9681","authenticated-orcid":false,"given":"Yoon Kyung","family":"Jeon","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"8Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea"},{"name":"10Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"6769","key":"2026032014071169900_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"2026032014071169900_bib2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"2026032014071169900_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"15","key":"2026032014071169900_bib4","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"2026032014071169900_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"5","key":"2026032014071169900_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"20","key":"2026032014071169900_bib7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"21","key":"2026032014071169900_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026032014071169900_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11912-021-01155-2","article-title":"Molecular subgroups of diffuse large B cell lymphoma: biology and implications for clinical practice","volume":"24","author":"Weber","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"2026032014071169900_bib10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"2026032014071169900_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.17811","article-title":"Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?","volume":"196","author":"Morin","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"2026032014071169900_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma","volume":"8","author":"Shen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2026032014071169900_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjh.17132","article-title":"Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)","volume":"192","author":"Runge","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2026032014071169900_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bjh.17765","article-title":"Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort","volume":"195","author":"Mishina","year":"2021","journal-title":"Br J Haematol"},{"issue":"10","key":"2026032014071169900_bib15","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ccell.2023.09.004","article-title":"Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: the randomized GUIDANCE-01 trial","volume":"41","author":"Zhang","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"2026032014071169900_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000535938","article-title":"Molecular characterization and genetic subclassification comparison of diffuse large B-cell lymphoma: real-life experience with 74 cases","volume":"91","author":"Ivanova","year":"2024","journal-title":"Pathobiology"},{"issue":"9","key":"2026032014071169900_bib17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41375-022-01670-6","article-title":"A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma","volume":"36","author":"Mendeville","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"2026032014071169900_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"2026032014071169900_bib19","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.3324\/haematol.2019.220475","article-title":"Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma","volume":"105","author":"Nowakowski","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"2026032014071169900_bib20","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00277-018-3442-2","article-title":"The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms","volume":"97","author":"Hwang","year":"2018","journal-title":"Ann Hematol"},{"issue":"10","key":"2026032014071169900_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PAI.0000000000000843","article-title":"Comparison of the Lymph2Cx assay and Hans algorithm in determining the cell-of-origin of diffuse large B-cell lymphomas, not otherwise specified","volume":"28","author":"Cho","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"24","key":"2026032014071169900_bib22","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1182\/bloodadvances.2023010402","article-title":"Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study","volume":"7","author":"Urata","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2026032014071169900_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000561","article-title":"High-grade transformation of low-grade B-cell lymphoma: pathology and molecular pathogenesis","volume":"40","author":"Agbay","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2026032014071169900_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"issue":"9","key":"2026032014071169900_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"issue":"4","key":"2026032014071169900_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12308-019-00369-5","article-title":"Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study","volume":"12","author":"Jung","year":"2019","journal-title":"J Hematop"},{"issue":"8","key":"2026032014071169900_bib27","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3324\/haematol.2021.278301","article-title":"A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas","volume":"106","author":"Kim","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"2026032014071169900_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/PAS.0000000000001859","article-title":"Clinicopathologic and genetic features of primary T-cell lymphomas of the central nervous system: an analysis of 11 cases using targeted gene sequencing","volume":"46","author":"Yim","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2026032014071169900_bib29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000001932","article-title":"Pediatric-type indolent B-cell lymphomas with overlapping clinical, pathologic, and genetic features","volume":"46","author":"Lim","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2026032014071169900_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"28","key":"2026032014071169900_bib31","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"16","key":"2026032014071169900_bib32","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"4","key":"2026032014071169900_bib33","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"Plos Comput Biol"},{"issue":"24","key":"2026032014071169900_bib34","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.2022016095","article-title":"Minimal information for reporting a genomics experiment","volume":"140","author":"Dreval","year":"2022","journal-title":"Blood"},{"issue":"14","key":"2026032014071169900_bib35","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"2026032014071169900_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"issue":"1110","key":"2026032014071169900_bib37","first-page":"11.10.1","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"issue":"19","key":"2026032014071169900_bib38","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/nar\/gkr599","article-title":"SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data","volume":"39","author":"Wei","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"2026032014071169900_bib39","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2026032014071169900_bib40","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkw227","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2026032014071169900_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2026032014071169900_bib42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"issue":"16","key":"2026032014071169900_bib43","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"2026032014071169900_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"2026032014071169900_bib45","first-page":"2020","article-title":"KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing","author":"Jung","year":"2020","journal-title":"Database (Oxford)"},{"issue":"1","key":"2026032014071169900_bib46","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/s41598-017-04642-4","article-title":"Korean Variant Archive (KOVA): a reference database of genetic variations in the Korean population","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"2026032014071169900_bib47","first-page":"2326","article-title":"Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: real-world experience from a cancer center","volume":"109","author":"Zhu","year":"2024","journal-title":"Haematologica"},{"issue":"4","key":"2026032014071169900_bib48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"issue":"2","key":"2026032014071169900_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood.V98.2.486","article-title":"Low frequency of BCL-2\/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals","volume":"98","author":"Yasukawa","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2026032014071169900_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2026032014071169900_bib51","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/ajh.27430","article-title":"EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management","volume":"99","author":"Malpica","year":"2024","journal-title":"Am J Hematol"},{"issue":"3","key":"2026032014071169900_bib52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"2026032014071169900_bib53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.17708","article-title":"EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK\/STAT (STAT3) pathway mutations and unique clinicopathologic features","volume":"194","author":"Chapman","year":"2021","journal-title":"Br J Haematol"},{"issue":"7","key":"2026032014071169900_bib54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/bloodadvances.2022008550","article-title":"EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential","volume":"7","author":"Li","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"2026032014071169900_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J"},{"issue":"7","key":"2026032014071169900_bib56","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"2026032014071169900_bib57","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-21-2949","article-title":"Genetic subtyping and phenotypic characterization of the immune microenvironment and MYC\/BCL2 double expression reveal heterogeneity in diffuse large B-cell lymphoma","volume":"28","author":"Xu-Monette","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2026032014071169900_bib58","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","article-title":"The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma","volume":"39","author":"Steen","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1929\/2508178\/blooda_adv-2025-017049-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1929\/2508178\/blooda_adv-2025-017049-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:07:23Z","timestamp":1774030043000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/6\/1929\/566041\/Distribution-and-prognostic-impact-of-LymphGen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017049","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,24]]},"published":{"date-parts":[[2026,3,12]]}}}